Navigation Links
Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
Date:10/19/2010

MOUNTAIN VIEW, Calif., Oct. 19 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has reacquired the U.S. and Canadian rights for AZ-004 (Staccato® loxapine) from Biovail Laboratories International SRL ("BLS"), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE and TSX: VRX) ("Valeant").  AZ-004 is being developed for the rapid treatment of agitation in schizophrenia or bipolar disorder patients.  Alexza previously established a collaboration arrangement with BLS, to develop and commercialize AZ-004 in the U.S. and Canada, for which Alexza received a $40 million upfront payment.  On September 28, 2010, Biovail Corporation and Valeant Pharmaceuticals International completed their merger.  As part of the review of the merged company's commercial and development pipelines, BLS has decided not to continue the AZ-004 project pursuant to the terms of the agreements between BLS and Alexza.  Based on the comprehensive clinical development program conducted for AZ-004 and the significant unmet medical need for patients, physicians and caregivers, Alexza intends to seek one or more pharmaceutical partners for the worldwide development and commercialization of AZ-004.

"The transaction with BLS has been of great value in allowing us to advance the development of AZ-004 and to expand our understanding of the market opportunity for this novel therapeutic," said Thomas B. King, Alexza President and CEO.  "While we would have been pleased to continue what has been a great working relationship with BLS, we understand BLS' strategic interest in focusing on its core therapeutic areas.  We look forward to advancing the development of AZ-004 and will provide further details regarding this program after we have our follow-on meeting with the FDA."

Under the terms of the agreements, with this
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015  Johnson & Johnson (NYSE: JNJ ... for the investment community beginning at 8:30 a.m. (Eastern ... Regency Hotel in New Brunswick, New Jersey ... Paul Stoffels , M.D., Worldwide Chairman Pharmaceuticals, ... Worldwide Chairman, Pharmaceuticals will host the meeting. Dominic ...
(Date:4/20/2015)... DUBLIN , Apr. 14, 2015 Research and ... addition of the "US Proton Therapy Outlook - ... According to the US Proton Therapy Outlook: Market Opportunities ... will be home to almost 29 such centers ... current figure. Consequently, the market will breach the Billion ...
(Date:4/20/2015)... 2015  Ameritox,s Ingenuity Health, a leading provider of ... research at the National Council of Behavioral Health annual ... that nearly 25 percent of the samples collected from ... the prescribed antipsychotic medication. ... Medication ...
Breaking Medicine Technology:United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3
... Dec. 1, 2011 Mylan Inc. (Nasdaq: MYL ) ... Besylate and Atorvastatin Calcium Tablets, 2.5 mg/10 mg, 2.5 mg/20 mg, ... mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 ... Caduet ® Tablets, which are used in the treatment of ...
... 2011  Henry Schein, Inc., (NASDAQ: HSIC ), ... to office-based practitioners, announced today that Stanley Bergman, Chairman ... Paladino, the Company,s Executive Vice President and Chief Financial ... Program on December 6.  The conference is being held ...
Cached Medicine Technology:Henry Schein to Present at the NASDAQ OMX 27th Investor Program 2
(Date:4/20/2015)... Florida Hospital at Connerton Long Term Acute Care ... Medical, during the annual ceremony hosted at the Grand ... Officer, Debi Martoccio, received the Leadership Award for demonstrating ... recipients out of 113 hospitals nationwide. The hospital also ... contributions to the community as well as a separate ...
(Date:4/20/2015)... TROY Healthcare Solutions will be hosting ... software, which provides the ultimate level of security for ... the Anthem Suite Hotel in the Socrates Room, located ... , Beginning at 7 AM, TROY Healthcare Solutions will ... Healthcare Solutions will offer brief 15-20 minute presentations each ...
(Date:4/20/2015)... 2015 “ Verus ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... of purposes. , According to CNET, at least a ... 2013. It’s unfortunate that smartphones break so easily, but ...
(Date:4/20/2015)... "It's so hard to put into words ... I really thought I would just be paying for ... I've discovered is this need that other baby loss ... other and walk through this journey together," says Ramsey ... more from these families than I could ever hope ...
(Date:4/20/2015)... Spring Hill, FL (PRWEB) April 20, 2015 ... public health issue in the United States for decades. ... lives, lost productivity, healthcare costs and property damage each ... on its victims, as well as their families and ... Suncoast Rehabilitation Center is dedicated to raising ...
Breaking Medicine News(10 mins):Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 2Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 4
... Data transparency improves patient satisfaction scores, ... to more effectively,measure individual performance and improve ... By incorporating patient,satisfaction benchmarks established through Press ... Press Ganey score by 2 points within ...
... Jan. 25 Super Bowl Sunday,s almost here-and,what better ... healthy,and losing some weight. Right? As more than 90 ... biggest event of the year, we,plan parties predicting the ... With those big-guy pro,s gearing up for Super ...
... --New York, NY-- Researchers in Belgium have significantly advanced ... capacity to generate new insulin-producing beta cells. If the ... progenitor cells may represent an obvious target for therapeutic ... in the Jan. 25 issue of the research journal ...
... To Settle, LOS ANGELES, Jan. 25 An ... made recently,when it came to the table to settle ... was filed Dec. 21, 2007 in Orange,County Superior Court, ... approval by the Multnomah County Circuit Court and,should receive ...
... Va., Jan. 25 - In a speech,earlier this ... the,company was in the initial stages of offering ... executive vice president and CEO,of the National Community ... PBM industry badly needs to be reformed. The ...
... got calls from those who had gotten procedure ... Jan. 25 (HealthDay News) -- Patients who have had ... the screening for colorectal cancer, say University of Pennsylvania ... who received telephone mentoring from a trained "peer coach" ...
Cached Medicine News:Health News:Emory Healthcare Uses SciHealth to Improve Patient Satisfaction 2Health News:Super Bowl and SuperFoods: Play Smart 2Health News:Elusive pancreatic progenitor cells found in mice 2Health News:Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit 2Health News:Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit 3Health News:NCPA Statement on Wal-Mart's Entry Into the Pharmacy Benefit Market 2Health News:Colonoscopy 'Coaches' Play Lifesaving Role 2
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
The popular E2002 Utrata Capsulorhexis Forceps with fine angled sharp tips. Angled 12 mm shafts with an iris stop. Flat handle with dull finish....
Fine angled tips ideal for grasping delicate capsule. Angled 12 mm shafts with iris stop allows ease of movement in the anterior chamber. Flat handle with dull finish. Manufactured in titanium....
Fine angled 12 mm shafts and iris stop. Round handle for fingertip rotational control. Dull finish....
Medicine Products: